4
Changes in Ownership
MapLight Therapeutics, Inc. Filed Acc 0001728746-26-000006
Chief Scientific Officer sold 4,513 shares at an average $27.16 ($122,574)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lillie James Woodruff Chief Scientific Officer | 2026-04-15 | Sale | −1,730 | $26.82 | $46,399 | 297,940 | D: show line 1 in the form |
| Lillie James Woodruff Chief Scientific Officer | 2026-04-16 | Sale | −686 | $27.01 | $18,529 | 297,254 | D: show line 2 in the form |
| Lillie James Woodruff Chief Scientific Officer | 2026-04-16 | Sale | −2,097 | $27.49 | $57,647 | 295,157 | D: show line 3 in the form |
| Open-market sales · 4,513 sh · avg $27.16 · $122,574 | |||||||
Loading xslF345X06/form4-04172026_040408.xml…